DE69123724D1 - Verfahren zur diagnose von hiv-infektionen - Google Patents

Verfahren zur diagnose von hiv-infektionen

Info

Publication number
DE69123724D1
DE69123724D1 DE69123724T DE69123724T DE69123724D1 DE 69123724 D1 DE69123724 D1 DE 69123724D1 DE 69123724 T DE69123724 T DE 69123724T DE 69123724 T DE69123724 T DE 69123724T DE 69123724 D1 DE69123724 D1 DE 69123724D1
Authority
DE
Germany
Prior art keywords
prosomes
extracellular
blood
suffering
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69123724T
Other languages
English (en)
Other versions
DE69123724T2 (de
Inventor
Klaus Scherrer
Jean-Paul Bureau
Faycal Bey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pro-Soma
Original Assignee
Pro-Soma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro-Soma filed Critical Pro-Soma
Publication of DE69123724D1 publication Critical patent/DE69123724D1/de
Application granted granted Critical
Publication of DE69123724T2 publication Critical patent/DE69123724T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/20—Coumarin derivatives
    • C12Q2337/22—7-Amino-4-methylcoumarin, i.e. AMC, MCA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
DE69123724T 1990-10-12 1991-10-11 Verfahren zur diagnose von hiv-infektionen Expired - Fee Related DE69123724T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90402863 1990-10-12
PCT/EP1991/001946 WO1992007270A1 (en) 1990-10-12 1991-10-11 Diagnostic method

Publications (2)

Publication Number Publication Date
DE69123724D1 true DE69123724D1 (de) 1997-01-30
DE69123724T2 DE69123724T2 (de) 1997-04-10

Family

ID=8205762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69123724T Expired - Fee Related DE69123724T2 (de) 1990-10-12 1991-10-11 Verfahren zur diagnose von hiv-infektionen

Country Status (8)

Country Link
EP (1) EP0506914B1 (de)
JP (1) JPH05502799A (de)
AT (1) ATE146597T1 (de)
AU (1) AU652192B2 (de)
CA (1) CA2069417A1 (de)
DE (1) DE69123724T2 (de)
FI (1) FI922667A7 (de)
WO (1) WO1992007270A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL440782A1 (pl) * 2022-03-29 2023-10-02 Urteste Spółka Akcyjna Związek - marker diagnostyczny raka jelita, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka jelita, zestaw zawierający taki związek oraz zastosowania takiego związku i sposób leczenia raka jelita

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586814A1 (fr) * 1985-08-30 1987-03-06 Centre Nat Rech Scient Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules
JPH01309686A (ja) * 1988-06-08 1989-12-14 Otsuka Pharmaceut Co Ltd 多機能プロテアーゼ

Also Published As

Publication number Publication date
AU652192B2 (en) 1994-08-18
CA2069417A1 (en) 1992-04-13
WO1992007270A1 (en) 1992-04-30
FI922667A0 (fi) 1992-06-09
EP0506914B1 (de) 1996-12-18
FI922667A7 (fi) 1992-06-09
JPH05502799A (ja) 1993-05-20
AU8740691A (en) 1992-05-20
DE69123724T2 (de) 1997-04-10
ATE146597T1 (de) 1997-01-15
EP0506914A1 (de) 1992-10-07

Similar Documents

Publication Publication Date Title
DE69228436D1 (de) Monoklonaler Antikörper, der den C-Terminus von hBNP erkennt
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
DK0528767T3 (da) antistofderivater
EP1035132A4 (de) Monoklonale antikörper zur apoptosis-induzierung
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
Norden et al. Schistosoma mansoni, S. haematobium, and S. japonicum: identification of genus-, species-, and gender-specific antigenic worm glycoproteins
UA24003A (uk) Спосіб визhачеhhя специфічhої сеhсибілізації лімфоцитів
EP0232179A3 (en) Assay for human breast cancer
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
FI922666A0 (fi) Diagnostiskt foerfarande.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
DE69123724D1 (de) Verfahren zur diagnose von hiv-infektionen
KR870700023A (ko) 녹농균의 E8Ag항원 및 그것에 대한 모노클로날 항체및 하이브리도마
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
ATE219247T1 (de) Methoden zur feststellung von alzheimerscher krankheit
Murray et al. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients
SE8205891D0 (sv) Alfa-l-antikropp och sett for framstellning derav
FR2608767B1 (fr) Procede pour la detection et le dosage des anticorps anti-(sporozoaires de p. falciparum) dans le sang humain et trousses de diagnostic pour mettre en oeuvre ce procede
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
EP0040020A3 (de) Menschliches Reverse-Transcriptase-Enzym, Verfahren zu seiner Reinigung und seine Verwendung zum Nachweis von Brustkrebs
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
SU1698764A1 (ru) Способ определени лиц, предрасположенных к респираторным заболевани м
ATE86261T1 (de) Tumorassoziiertes antigen.
ATE737T1 (de) Verfahren zur bestimmung eines opsonierenden oberflaechenbindenden alpha-2-glykoproteins.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee